NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.843
+0.010 (1.23%)
At close: Mar 6, 2026, 4:00 PM EST
0.840
-0.003 (-0.32%)
After-hours: Mar 6, 2026, 5:29 PM EST
Company Description
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
The company is based in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporation
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 18 |
| CEO | David Rosa |
Contact Details
Address: 7599 Anagram Drive Eden Prairie, Minnesota 55344 United States | |
| Phone | 952 426 1383 |
| Website | nmtc1.com |
Stock Details
| Ticker Symbol | NMTC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001500198 |
| CUSIP Number | 64130M209 |
| ISIN Number | US64130M2098 |
| Employer ID | 27-0863354 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David A. Rosa M.D. | President, Chief Executive Officer and Director |
| Ronald W. McClurg | Chief Financial Officer |
| Christopher R. Volker CFA | Chief Operating Officer |
| Mark Christianson | Co-Founder, Business Development Director and Medical Sales Liaison |
| Steven Mertens | Chief Technology Officer |
| Emily Johns | Chief Administrative Officer and General Counsel |
| Hijaz Haris | Vice President of Marketing |
| Dr. Parag G. Patil M.D., Ph.D. | Chief Medical Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 27, 2026 | PRE 14A | Other preliminary proxy statements |
| Feb 25, 2026 | 8-K | Current Report |
| Feb 17, 2026 | 8-K | Current Report |
| Feb 17, 2026 | 10-Q | Quarterly Report |
| Jan 23, 2026 | 10-K/A | [Amend] Annual report |
| Dec 22, 2025 | 8-K | Current Report |
| Dec 19, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Dec 17, 2025 | 8-K | Current Report |
| Dec 17, 2025 | 10-K | Annual Report |
| Dec 16, 2025 | SD | Form - SD |